Companies · Other Health Care

Active Implants Corp

MEMPHIS · Other Health Care

Diligence memoA one-page analyst read on Active Implants Corp — recommendation, valuation, rhythm, risks.
$35.8M
Total raised · real
5
Rounds
0.4×
Latest step-up
Top 11%
Sector rank · raised
Series A
Latest stage · inferred · Thu Mar 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time)

Active Implants Corp looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.44× the median modeled value of Series A Other Health Care companies in 2010–2012 (199 peers) — value vs value, same stage and era.
  • Within the normal band (144% of peer median) for its niche.
Dormant
  • Last raise 15.3 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Active Implants Corp is one of 5377 Other Health Care companies tracked from MEMPHIS. By capital raised it ranks among the largest (ahead of 90% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeries A · 2009-03-13 Raised $15M (real) Modeled valuation $303M (est)$15M$303MSeries A2009Series A · 2009-03-13 Raised $8.6M (real) Modeled valuation $173M (est)$8.6M$173MSeries A2009Pre-Seed · 2009-03-13 Raised $750K (real) Modeled valuation $23M (est)$750K$23MPre-Seed2009Series A · 2011-03-31 Raised $8.3M (real) Modeled valuation $168M (est)$8.3M$168MSeries A2011Series A · 2011-03-31 Raised $3.1M (real) Modeled valuation $63M (est)$3.1M$63MSeries A2011+$8.6M+$750K+$8.3M+$3.1MCumulative $36M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$15.0M · 2009
Series A extension$8.6M · 2009
Bridge · Series A-stage$750K · 2009smaller follow-on
Series A extension$8.3M · 2011
Series A extension$3.1M · 2011

Stages are modeled from round size (public records carry no series label). No record for: Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$167.9M
Base estimate est.
$10.7M
Conservative case
$912.9M
Upside case
$37.8M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $302.7M · 2009-03-132009Series A · modeled $173.3M · 2009-03-13Pre-Seed · modeled $23.1M · 2009-03-13Series A · modeled $167.9M · 2011-03-31Series A · modeled $63.1M · 2011-03-312011
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
15.3 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
6 mo
Avg between rounds
$17.5M/yr
Capital velocity
17.3 yr
On record since
2009
First round
5
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 15× above median
This company$35.8M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.6× of median
This company$3.1M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 7.6× above median
This company$167.9M
Sector median$22.1M

Raised more than 90% of sector peers (real $). Modeled value above 86% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #52 of 199.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)Barrx Medical Inc · Series A Raised $15.0M · modeled $302.7M (est)Icad Inc · Series A Raised $27.1M · modeled $302.7M (est)Cas Medical Systems Inc · Series A Raised $16.9M · modeled $302.7M (est)Cardiosolutions Inc · Series A Raised $18.5M · modeled $300.3M (est)Ophthonix Inc · Series A Raised $24.7M · modeled $283.4M (est)FMS Watertown, LLC · Series A Raised $13.7M · modeled $277.2M (est)Flowood Vascular Access, LLC · Series A Raised $13.7M · modeled $277.2M (est)Cardiovascular Systems Inc · Series A Raised $58.5M · modeled $272.4M (est)HemaSource Holdings LLC · Series A Raised $13.5M · modeled $272.2M (est)OMNI Home Health Acquisition, LLC · Series A Raised $12.6M · modeled $253.2M (est)Integrated Sleep Holdings Inc · Series A Raised $12.4M · modeled $249.9M (est)AngioScore Inc. · Series A Raised $12.0M · modeled $242.2M (est)Active Implants Corp (this company) Raised $35.8M · modeled $167.9M (est)Active Implants Corp
CompanyStageRaised · realValue · estvs peer med.
Barrx Medical IncSeries A$15.0M$302.7M2.60×
Icad IncSeries A$27.1M$302.7M2.60×
Cas Medical Systems IncSeries A$16.9M$302.7M2.60×
Cardiosolutions IncSeries A$18.5M$300.3M2.58×
Ophthonix IncSeries A$24.7M$283.4M2.44×
FMS Watertown, LLCSeries A$13.7M$277.2M2.38×
Flowood Vascular Access, LLCSeries A$13.7M$277.2M2.38×
Cardiovascular Systems IncSeries A$58.5M$272.4M2.34×
HemaSource Holdings LLCSeries A$13.5M$272.2M2.34×
OMNI Home Health Acquisition, LLCSeries A$12.6M$253.2M2.18×
Integrated Sleep Holdings IncSeries A$12.4M$249.9M2.15×
AngioScore Inc.Series A$12.0M$242.2M2.08×
Active Implants Corp this companySeries A$35.8M$167.9M1.44×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$15.0M2009-03-13$68.2M$302.7M90%
Series A$8.6M2009-03-13$39.0M$173.3M90%
Pre-Seed$750K2009-03-13$4.2M$23.1M90%
Series A$8.3M2011-03-31$37.8M$167.9M90%
Series A$3.1M2011-03-31$14.2M$63.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$15.0M2009-03-13
    • First recorded raise — entered as Series A.
  2. Series A$8.6M2009-03-13
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.7× smaller than the prior — bridge or down round.
  3. Pre-Seed$750K2009-03-13
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 11.4× smaller than the prior — bridge or down round.
  4. Series A$8.3M2011-03-31
    • Raised again after 25 mo — slower than the ~14 mo sector norm.
    • Round 11.1× larger than the prior — scaling up.
  5. Series A$3.1M2011-03-31
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.7× smaller than the prior — bridge or down round.
Intelligence
2011 ~Q4
Modeled next raise · ~6mo cadence
$3.1M
Modeled next size est.range $3.1M$5.0M
0.4×
Last step-up
$17.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Michael Lewis11 other2009-03
Dennis Long3 other2009-03
Charles Martin2 other2009-03
Henry Klyce1 other2009-03
Jack Blair1 other2009-03
James Lackie1 other2009-03
Lawrence Kluge1 other2011-03
Michael Mainelli1 other2009-03
Richard Treharne1 other2009-03
William Mays, Jr.1 other2011-03
Amiram Steinberg2009-03
Larry Kluge2009-03
Michael Keenan2009-03
Noam Weissberg2009-03
Stephen Bradshaw2009-03
Thomas Buford2011-03
Troy Drewry2009-03
Registry & provenance

Active Implants Corp is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1312573
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
BeneChill, Inc.Other Health CareSeries A$35.7M$132.7Msame sector · same stage
Carena IncOther Health CareSeries A$37.2M$121.1Msame sector · same stage
Urgent Care Centers of New England, Inc.Other Health CareSeries A$32.7M$186.0Msame sector · same stage
Sunniva Inc.Other Health CareSeries A$32.2M$121.1Msame sector · same stage
Trio Medical CorpHealthtechSeed$1.4M$9.7Mnetwork3 shared operators
TrueVision Systems IncOther Health CareSeries A$31.1M$185.9Msame sector · same stage
Thermedical, Inc.Other Health CareSeries A$30.5M$217.0Msame sector · same stage
Zipari, Inc.Other Health CareSeries A$29.6M$208.3Msame sector · same stage
Frequently asked
How much funding has Active Implants Corp raised?
Active Implants Corp has raised approximately $35.8M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Active Implants Corp's estimated valuation?
Provath's modeled valuation for Active Implants Corp is approximately $167.9M (modeled range $10.7M–$912.9M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Active Implants Corp at?
Active Implants Corp's latest modeled financing stage is Series A. Its most recent recorded round closed around Thu Mar 31.
What does Active Implants Corp do and where is it based?
Active Implants Corp operates in the Other Health Care sector, based in MEMPHIS.
Explore related

See where Active Implants Corp sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Active Implants Corp, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.